跳至主要内容
临床试验/IRCT20220806055624N1
IRCT20220806055624N1尚未招募未知

The effect of boron citrate supplementation on nutritional status, cardiometabolic factors, and inflammatory indices of TNF-a, IL-10, IL-6, and CRP in obese people

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • BMI: 30–40 (kg/m²)
  • Willingness to participate in the study

排除标准

  • Athlete, pregnancy, lactation and menopause in women
  • Under infertility treatment, taking birth control pills and estrogen
  • Smoking and history of alcohol consumption
  • Following a special diet three months before the study
  • Use of chemical or herbal drugs for weight loss and use of hepatotoxic drugs such as phenytoin, amoxifene, lithium, blood pressure control drugs and blood lipid lowering drugs (statins), drugs that increase insulin sensitivity.
  • Taking antibiotics or supplements affecting liver enzyme levels
  • Weight loss surgery in the last year or strict weight loss diets in the last three months
  • Using corticosteroid and non-steroidal anti-inflammatory drugs and any supplements for 3 months before the study or during the study
  • Cardiovascular diseases, liver, kidney, intestinal, thyroid and parathyroid dysfunction, biliary disease, known autoimmune diseases, polycystic ovary syndrome, cancers and malabsorption diseases such as sprue and Crohn's
  • Having symptoms of infectious or inflammatory disease or recent surgery
  • Performed or candidate for liver transplant

研究者

相似试验